Edwards Lifesciences (EW) Superinvestor holders
26 of the superinvestors we track hold Edwards Lifesciences (EW) in their latest 13F filings, $3.4B in total.
Summary
The largest holder is Howard Gleicher (Aristotle Capital Management), with $784M, 1.6% of the portfolio.
In their latest quarter: 1 opened a new position, 12 added, 12 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Howard Gleicher Aristotle Capital Management |
New position | 8,665,712 | $784M | 1.6% | Q2 2026 |
| Artisan Partners | Added | 6,625,703 | $599M | 1.0% | Q2 2026 |
| Arrowstreet Capital | Added | 5,677,344 | $514M | 0.2% | Q2 2026 |
| PRIMECAP Management PRIMECAP Management Co |
Trimmed | 3,408,291 | $308M | 0.2% | Q2 2026 |
| Brandon Haley Holocene Advisors |
Added | 3,139,285 | $284M | 0.7% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
Trimmed | 1,774,120 | $160M | 0.3% | Q2 2026 |
| Baillie Gifford Baillie Gifford & Co |
Added | 1,740,553 | $150M | 0.1% | Q3 2026 |
| Two Sigma Two Sigma Investments |
Added | 1,521,899 | $138M | 0.1% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Trimmed | 1,465,185 | $132M | 0.0% | Q2 2026 |
| Man Group Man Group plc |
Trimmed | 935,186 | $85M | 0.2% | Q2 2026 |
| Acadian Acadian Asset Management |
Added | 500,857 | $43M | 0.1% | Q3 2026 |
| Paul Marshall Marshall Wace |
Trimmed | 344,361 | $31M | 0.0% | Q2 2026 |
| Tony Yoseloff Davidson Kempner Capital Management |
Added | 317,500 | $29M | 0.7% | Q2 2026 |
| Ray Dalio Bridgewater Associates |
Added | 275,279 | $25M | 0.1% | Q2 2026 |
| Jennison Associates | Trimmed | 238,403 | $22M | 0.0% | Q2 2026 |
| Ron Baron Baron Capital (BAMCO) |
Added | 229,603 | $21M | 0.0% | Q2 2026 |
| David Rolfe Wedgewood Partners |
Trimmed | 165,208 | $15M | 3.1% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Trimmed | 159,272 | $14M | 0.0% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
Trimmed | 100,271 | $9M | 0.0% | Q2 2026 |
| Ken Fisher Fisher Investments |
Trimmed | 80,503 | $7M | 0.0% | Q3 2026 |
| Alan Howard Brevan Howard |
Added | 34,889 | $3M | 0.0% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Trimmed | 21,000 | $2M | 0.0% | Q2 2026 |
| Jeremy Grantham GMO |
Added | 20,664 | $2M | 0.0% | Q2 2026 |
| Fayez Sarofim Fayez Sarofim & Co |
Added | 10,071 | $911,023 | 0.0% | Q2 2026 |
| Alger Fred Alger Management |
Trimmed | 9,670 | $874,748 | 0.0% | Q2 2026 |
| Robert Torray Torray Investment Partners |
Held | 2,994 | $258,442 | 0.0% | Q3 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 26 |
| Q1 2026 | 26 |
| Q4 2025 | 24 |
| Q3 2025 | 23 |
| Q2 2025 | 27 |
| Q1 2025 | 28 |
| Q4 2024 | 30 |
| Q3 2024 | 31 |
Questions about Edwards Lifesciences
Which superinvestors own Edwards Lifesciences?
26 of the superinvestors we track hold Edwards Lifesciences (EW) in their latest 13F filings, $3.4B in total. Howard Gleicher, Artisan Partners, Arrowstreet Capital, PRIMECAP Management, Brandon Haley, Steve Cohen.
Who is the largest superinvestor holder of EW?
The largest holder is Howard Gleicher (Aristotle Capital Management), with $784M, 1.6% of the portfolio.
From Edwards Lifesciences's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.